进口调节阀

进口调节阀

进口减压阀

进口电磁阀

江苏尼科医疗器械有限公司成立于2011年3月,坐落在无锡滨湖区湖景科技园,公司为无锡市530企业,将国外先进的技术引进国内,专注于神经介入产品的研发及生产。


  近年来我国脑神经血管病例成倍增长,其中脑卒中患者每年新增200多万例。药物溶栓治疗是过去最常用的治疗方法,2015年,新英格兰杂志连续刊登了5个国际临床研究,均显示急性期缺血性卒中介入取栓治疗明显优于静脉溶栓,机械取栓已成为脑卒中治疗的金标准;仅仅1年,我国急性缺血性卒中取栓应用与研究取得了突飞猛进的发展,器械取栓也被列入《急性缺血性脑卒中血管内治疗中国指南2015》,江苏尼科医疗器械有限公司作为国内第一个研发、生产取栓器械的公司,研发的产品已被评为创新医疗器械,通知书编号:201600107。


  为填补国内物理介入取栓装置的空白,实现取栓装置国产化,尼科医疗已自主开发两种型号(I型和II型)、多尺寸要求的脑血栓取出装置以及各种神经介入导管,能根据颅内狭窄血管的不同形态特征,提供较为全面的治疗措施,公司在中、美、欧洲已获得多项专利,取栓装置于2016年顺利通过欧洲医疗器械CE认证。


  公司首个产品脑血栓取出装置已于2018年5月11日获得CFDA批准上市。

 

Founded in 2011,Minitech Medical Ltd. is specializing in interventional neurological devices treating stroke patients.In October 2012, company was granted permission for Class III Medical Device Manufacturing by CFDA.  RECO™ Clot Retriever was CE Marked in August 2016.


Stroke has been the leading cause of disability and death in the world.Every year there are more than 2 million new stroke cases in China.


Occlusion of proximal intracranial arteries is a common cause of acute ischemic stroke and causes much  disability and mortality. Treatments for ischemic stroke that are approved by guidelines or regulatory authorities include systematic supportive care in a stroke unit or stroke centre, prevention of clot propagation with  aspirin, and achievement of reperfusion through use of intravenous recombinant tissue plasminogen activator (rt-PA) until 4.5h after onset,  intraarterial fibrinolysis until 6h after onset, and  mechanical thrombectomy up to 24h after onset.


Minitech Medical Ltd. offer products including clot retriever RECO™, balloon guide catheters  Ewata™, microcatheters,intermediate catheters,devices for treating aneurysm etc.


  With a strong  product portfolio, Minitech Medical Ltd. is leading the way of stroke treatments both within China and around the world,and the cpmpany has multiple patents in China,US,and EU.


CFDA granted Reco clot retriever product registration for marketing on May 11, 2018.